A Pilot Study of Telmisartan (Micardis) for the Prevention of Acute Graft Versus Host Disease Post Allogeneic Hematopoietic Stem Cell Transplantation - Regional Cancer Care Associates LLC

Clinical Trials

A Pilot Study of Telmisartan (Micardis) for the Prevention of Acute Graft Versus Host Disease Post Allogeneic Hematopoietic Stem Cell Transplantation

Type of Cancer

Warning: implode(): Invalid arguments passed in /home/region33/public_html/wp-content/themes/regionalcancercenter/single-clinical-trials.php on line 42
Locations
Sponsor
Hackensack UMC
Protocol Number
Hackensack UMC Telmisartan for the Prevention of GvHD
Cancer Diagnosis
To Learn More Call
201-510-0910